Skip to main content
Top
Published in: Israel Journal of Health Policy Research 1/2015

Open Access 01-12-2015 | Commentary

The importance of science-informed policy and what the data really tell us about e-cigarettes

Authors: David B. Abrams, Raymond Niaura

Published in: Israel Journal of Health Policy Research | Issue 1/2015

Login to get access

Abstract

A possible future end-game for cigarettes is explored in the context of the historical progress made to date by tobacco control. Despite good progress, there remains an urgent need to increase the use of proven tobacco control policies and practices for prevention and cessation. The problem is worse than previously thought and the 50th anniversary United States Surgeon General’s report indicates the overwhelming majority of avoidable deaths are caused by combusting of tobacco, primarily cigarettes. The report highlights for the first time the addition of a harm minimization strategy to enhance proven tobacco control efforts and thus much more rapidly speed the obsolescence of cigarettes. Harm minimization can be two pronged. First, it can boost proven tobacco control polices to make cigarettes more expensive and less appealing and accessible to maximize the fact that cigarettes are orders of magnitude the most harmful of all tobacco delivery systems. Second, harm minimization can support use of substantially less harmful but appealing alternatives to substitute for lethal cigarettes for those users who are unable or unwilling to quit smoking. A future end-game might prudently manage emerging new products like e-cigarettes to help boost the difference in harm between them and lethal cigarettes. Harm minimization could help to accelerate the end of the century-long dominance of the cigarette in what has been called “the golden holocaust”. Rather than these emerging delivery devices being used to replace lethal cigarettes in what might be termed a David versus Goliath strategy to disrupt the status quo, there is also legitimate concern that these new products could undermine historically successful tobacco control efforts, especially youth prevention, if allowed free reign. What can the data really tell us about the potential for e-cigarettes to be helpful or harmful? The emerging but limited scientific evidence and the inherent methodological constraints in study designs, points to the need for caution in prematurely interpreting results in a manner that could mislead policymakers.
Literature
2.
go back to reference Beaglehole R, Bonita R, Yach D, et al. A tobacco-free world: a call to action to phase out the sale of tobacco products by 2040. Lancet. 2015;385(9972):1011–8.PubMedCrossRef Beaglehole R, Bonita R, Yach D, et al. A tobacco-free world: a call to action to phase out the sale of tobacco products by 2040. Lancet. 2015;385(9972):1011–8.PubMedCrossRef
3.
go back to reference U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
4.
go back to reference Brandt AM. The Cigarette Century: The Rise, Fall and Deadly Persistence of the Product that defined America. New York, NY: Basic Books; 2007. Brandt AM. The Cigarette Century: The Rise, Fall and Deadly Persistence of the Product that defined America. New York, NY: Basic Books; 2007.
6.
go back to reference Proctor RN. Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition. Berkeley and Los Angeles, CA: University of California Press; 2011. Proctor RN. Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition. Berkeley and Los Angeles, CA: University of California Press; 2011.
9.
go back to reference Warner KE, Pollack HA. The Nicotine Fix. The Atlantic, 2014. Warner KE, Pollack HA. The Nicotine Fix. The Atlantic, 2014.
10.
go back to reference Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014;311(2):135–6.PubMedCrossRef Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014;311(2):135–6.PubMedCrossRef
11.
go back to reference Zeller M, Hatsukami D. Strategic dialogue on tobacco harm reduction G. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US Tob Control. 2009;18(4):324–32. Zeller M, Hatsukami D. Strategic dialogue on tobacco harm reduction G. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US Tob Control. 2009;18(4):324–32.
12.
go back to reference Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among US adolescents: a cross-sectional study. JAMA Pediatr. 2014;168(7):610–7.PubMedCentralPubMedCrossRef Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among US adolescents: a cross-sectional study. JAMA Pediatr. 2014;168(7):610–7.PubMedCentralPubMedCrossRef
13.
go back to reference Niaura RS, Glynn TJ, Abrams DB. Youth experimentation with e-cigarettes: another interpretation of the data. JAMA. 2014;312(6):641–2.PubMedCrossRef Niaura RS, Glynn TJ, Abrams DB. Youth experimentation with e-cigarettes: another interpretation of the data. JAMA. 2014;312(6):641–2.PubMedCrossRef
14.
go back to reference Arrazola RA, Singh T, Corey CG, et al. Tobacco use among middle and high school students - United States, 2011–2014. MMWR Morb Mortal Wkly Rep. 2015;64(14):381–5.PubMed Arrazola RA, Singh T, Corey CG, et al. Tobacco use among middle and high school students - United States, 2011–2014. MMWR Morb Mortal Wkly Rep. 2015;64(14):381–5.PubMed
15.
go back to reference Centers for Disease C, Prevention. Tobacco product use among middle and high school students–United States, 2011 and 2012. MMWR Morb Mortal Wkly Rep. 2013;62(45):893–7. Centers for Disease C, Prevention. Tobacco product use among middle and high school students–United States, 2011 and 2012. MMWR Morb Mortal Wkly Rep. 2013;62(45):893–7.
17.
go back to reference Adkison SE, O’Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013;44(3):207–15.PubMedCentralPubMedCrossRef Adkison SE, O’Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013;44(3):207–15.PubMedCentralPubMedCrossRef
18.
go back to reference Vickerman KA, Carpenter KM, Altman T, et al. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res. 2013;15(10):1787–91.PubMedCrossRef Vickerman KA, Carpenter KM, Altman T, et al. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res. 2013;15(10):1787–91.PubMedCrossRef
20.
go back to reference Pearson JL, Stanton CA, Cha S, et al. E-cigarettes and smoking cessation: insights and cautions from a secondary analysis of data from a study of online treatment-seeking smokers. Nicotine Tob Res 2014. [Epub ahead of print]. Pearson JL, Stanton CA, Cha S, et al. E-cigarettes and smoking cessation: insights and cautions from a secondary analysis of data from a study of online treatment-seeking smokers. Nicotine Tob Res 2014. [Epub ahead of print].
21.
go back to reference Bullen C, Howe C, Laugesen M. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37.PubMedCrossRef Bullen C, Howe C, Laugesen M. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37.PubMedCrossRef
22.
go back to reference Caponnetto P, Campagna D, Cibella F, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317.PubMedCentralPubMedCrossRef Caponnetto P, Campagna D, Cibella F, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317.PubMedCentralPubMedCrossRef
23.
go back to reference Fiore M. Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. Darby, PA: DIANE Publishing; 2008. Fiore M. Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. Darby, PA: DIANE Publishing; 2008.
24.
go back to reference Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127–33.PubMedCrossRef Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127–33.PubMedCrossRef
26.
go back to reference Fiore MC, Schroeder SA, Baker TB. Smoke, the chief killer–strategies for targeting combustible tobacco use. N Engl J Med. 2014;370(4):297–9.PubMedCrossRef Fiore MC, Schroeder SA, Baker TB. Smoke, the chief killer–strategies for targeting combustible tobacco use. N Engl J Med. 2014;370(4):297–9.PubMedCrossRef
27.
go back to reference Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19(2):98–103.PubMedCrossRef Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19(2):98–103.PubMedCrossRef
28.
go back to reference Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2014;231(2):401–7.CrossRef Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2014;231(2):401–7.CrossRef
29.
go back to reference Dawkins L, Turner J, Hasna S, et al. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav. 2012;37(8):970–3.PubMedCrossRef Dawkins L, Turner J, Hasna S, et al. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav. 2012;37(8):970–3.PubMedCrossRef
30.
go back to reference Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1945–53.PubMedCentralPubMedCrossRef Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1945–53.PubMedCentralPubMedCrossRef
31.
go back to reference Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction. 2012;107(8):1493–500.PubMedCentralPubMedCrossRef Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction. 2012;107(8):1493–500.PubMedCentralPubMedCrossRef
32.
go back to reference Cobb NK, Abrams DB. The FDA, e-cigarettes and the demise of combusted tobacco. N Engl J Med. 2014;371(16):1469–71.PubMedCrossRef Cobb NK, Abrams DB. The FDA, e-cigarettes and the demise of combusted tobacco. N Engl J Med. 2014;371(16):1469–71.PubMedCrossRef
33.
go back to reference Kozlowski LT. Prospects for a nicotine-reduction strategy in the cigarette endgame: altnernative tobacco harm reduction scenarios. Int J Drug Policy. 2015. doi: 10.1016/j.drugpo.2015.02.001. Kozlowski LT. Prospects for a nicotine-reduction strategy in the cigarette endgame: altnernative tobacco harm reduction scenarios. Int J Drug Policy. 2015. doi: 10.1016/j.drugpo.2015.02.001.
34.
go back to reference Cobb CO, Villanti AC, Graham AL, et al. Markov modeling to estimate the population impact of emerging tobacco products: a proof-of concept study. Tobacco Regulatory Science. 2015;1(2):121–41. Cobb CO, Villanti AC, Graham AL, et al. Markov modeling to estimate the population impact of emerging tobacco products: a proof-of concept study. Tobacco Regulatory Science. 2015;1(2):121–41.
35.
go back to reference Sweanor D. Disruptive technology: a blessing and a curse. Rulebreaker Research. 2014:54–57. Sweanor D. Disruptive technology: a blessing and a curse. Rulebreaker Research. 2014:54–57.
36.
Metadata
Title
The importance of science-informed policy and what the data really tell us about e-cigarettes
Authors
David B. Abrams
Raymond Niaura
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2015
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-015-0021-z

Other articles of this Issue 1/2015

Israel Journal of Health Policy Research 1/2015 Go to the issue